Coagulation Cascade Diagram Generator

What is the coagulation cascade?

When a blood vessel is cut, the body stops the bleeding in overlapping stages called hemostasis. The vessel wall constricts (vascular spasm), platelets stick to the exposed collagen and to each other to form a soft plug (primary hemostasis), and then the coagulation cascade turns the liquid blood around the plug into a solid clot (secondary hemostasis). The cascade is a chain of plasma proteins called clotting factors, most made by the liver, that circulate in an inactive form. Each one, once activated, activates the next, so a tiny trigger is amplified at every step into a flood of thrombin.

Thrombin is the enzyme that makes the clot. It cuts soluble fibrinogen into fibrin, which polymerises into a mesh of strands that traps red cells and platelets, and it activates factor XIII, which cross-links those strands so the clot holds. A coagulation cascade diagram is the map of that chain. In its classic form it has three parts — the intrinsic, extrinsic, and common pathways — and its value as a teaching figure depends almost entirely on getting the Roman numerals in the right boxes and the arrows pointing the right way.

Primary vs secondary hemostasis: where the clotting cascade fits

A clotting cascade diagram shows only one part of hemostasis, and it helps to know which part. Primary hemostasis is the platelet plug: von Willebrand factor tethers platelets to exposed collagen through their GPIb receptors, the platelets activate, change shape, and release ADP and thromboxane A2, which recruit and activate more platelets until a soft plug seals the hole. Secondary hemostasis is the coagulation cascade, which builds a fibrin mesh through and around that plug so it can withstand arterial pressure. The two are not separate in time — activated platelets provide the phospholipid surface on which the tenase and prothrombinase complexes assemble, and thrombin activates more platelets — but they fail in different ways. Platelet and von Willebrand problems tend to cause bleeding from skin and mucous membranes, while clotting factor deficiencies such as hemophilia tend to cause deep bleeding into joints and muscles. Draw the platelet plug on a cascade diagram only if the request asks for it.

Coagulation cascade diagram: what to label

• The three pathway names: intrinsic (contact activation), extrinsic (tissue factor), and common.
• The intrinsic factors, top to bottom: XII → XIIa, XI → XIa, IX → IXa, with VIIIa as the cofactor of IXa.
• The extrinsic factors: tissue factor (factor III) and VII → VIIa.
• The meeting point: factor X → Xa, with cofactor Va.
• The conversion steps of the common pathway: prothrombin (II) → thrombin (IIa), and fibrinogen (I) → fibrin (Ia).
• Factor XIII → XIIIa, activated by thrombin, and the cross-linked fibrin clot it produces.
• Calcium (Ca²⁺, factor IV) at the tenase and prothrombinase complexes.
• Optional, if asked for: triggers (contact surface, tissue damage), positive feedback from thrombin, the PT and aPTT brackets, anticoagulant regulation, and fibrinolysis.

The intrinsic pathway step by step

The intrinsic pathway is also called the contact activation pathway, because it starts when factor XII (Hageman factor) touches a negatively charged surface — in the laboratory, glass or the activators added to an aPTT tube. Prekallikrein and high-molecular-weight kininogen help XII become XIIa. XIIa activates factor XI to XIa, and XIa, with calcium, activates factor IX to IXa. IXa on its own is a weak enzyme; it becomes a powerful one when it assembles with its cofactor VIIIa and calcium on a phospholipid membrane, mainly the surface of activated platelets. That assembly is called the intrinsic tenase complex, and it activates factor X. OpenStax describes the whole pathway as taking a few minutes. On a diagram, draw it as a column of four steps on one side of the Y, with VIIIa shown as a partner attached to IXa rather than as a fourth link in the chain.

The extrinsic pathway step by step

The extrinsic pathway, or tissue factor pathway, is short and fast. Damaged cells outside the vessel expose tissue factor, a membrane protein that is called factor III in the old numbering and thromboplastin in older texts. Tissue factor binds factor VII from the plasma, which becomes VIIa, and with calcium the pair forms the extrinsic tenase complex, which activates factor X directly. OpenStax describes these events as completed in a matter of seconds. In the body this is the pathway that actually starts clotting after an injury, which is why it is drawn as the trigger on the opposite side of the Y. In the classic diagram it joins the intrinsic pathway at factor X; the extra link by which tissue factor–VIIa also activates factor IX belongs on more detailed or cell-based diagrams.

The common pathway: from factor X to a cross-linked fibrin clot

Everything below factor X is the common pathway, shared by both upstream routes. Factor Xa assembles with its cofactor Va, calcium, and a phospholipid surface into the prothrombinase complex. Prothrombinase converts prothrombin, factor II, into thrombin, factor IIa — and because each Xa molecule makes many thrombin molecules, this is where the amplification of the cascade pays off.

Thrombin then does three jobs. It cleaves fibrinogen, factor I, into fibrin monomers, factor Ia, which line up and polymerise into strands. It activates factor XIII to XIIIa, which forms covalent cross-links between neighbouring fibrin strands and turns a loose mesh into a stable clot. And it feeds back up the cascade, activating factors V, VIII, and XI and activating platelets, which speeds its own production. A common-pathway diagram should therefore end fibrinogen → fibrin → cross-linked fibrin, with thrombin on the first arrow and XIIIa on the second.

Clotting cascade made easy: memory tricks for the factor numbers

Most students do not struggle with the idea of a cascade; they struggle with the numerals. The trick is to learn three short lists and a few rules. Intrinsic: 12, 11, 9, 8 — a popular way to remember it is that the intrinsic pathway "costs $12, or $11.98". Extrinsic: 3 and 7 — tissue factor plus factor VII. Common: 10, 5, 2, 1, then 13 — X with V makes thrombin from II, thrombin makes fibrin from I, and XIII stabilises the result.

Then add the rules that catch people out. IV is calcium, not a protein. There is no factor VI. II, VII, IX, and X are the vitamin K–dependent factors, which you can remember as "1972": ten, nine, seven, two. V and VIII are cofactors, not enzymes. And XIII is never upstream of fibrin. A coagulation cascade made easy diagram colour-codes the three lists — one colour for each pathway — so that a student can check any numeral against its column at a glance.

The cell-based model of coagulation

The classic cascade was built from test-tube experiments, and it explains clotting tests very well. It explains bleeding less well. If the extrinsic pathway can activate factor X on its own, why do people who lack factor VIII or IX — hemophilia A and B — bleed so badly? And why does a lack of factor XII, which prolongs the aPTT, cause no bleeding at all? In 2001 Hoffman and Monroe proposed a cell-based model that answers both questions by placing the reactions on cell surfaces in three overlapping phases.

In initiation, tissue factor–VIIa on a tissue-factor-bearing cell outside the vessel makes small amounts of Xa and IXa, and Xa with Va produces a little thrombin — not enough to clot, but enough to signal. In amplification, that thrombin activates nearby platelets and factors V, VIII, and XI, and releases VIII from its carrier, von Willebrand factor. In propagation, the activated platelet surface hosts the tenase complex (IXa–VIIIa) and the prothrombinase complex (Xa–Va), which together produce a burst of thrombin large enough to form a stable clot. Because the burst depends on IXa and VIIIa, a missing factor VIII or IX still causes bleeding, and because factor XII plays no part, its absence does not.

Coagulation tests on the diagram: PT/INR and aPTT

The two everyday clotting tests map neatly onto the classic diagram, which is why medical courses still teach it. The prothrombin time (PT), reported internationally as the INR, starts clotting with tissue factor, so it tests the extrinsic and common pathways: factors VII, X, V, II, and I. The activated partial thromboplastin time (aPTT) starts clotting with a contact activator, so it tests the intrinsic and common pathways: factors XII, XI, IX, VIII, X, V, II, and I. Reading them together localises a problem. A prolonged PT with a normal aPTT points at factor VII; a prolonged aPTT with a normal PT points at the intrinsic factors; both prolonged suggests the common pathway, several factors at once, or an anticoagulant. Warfarin is monitored with the PT/INR, and unfractionated heparin with the aPTT. Drawing the two tests as brackets on the cascade is the clearest way to show all of this on one figure.

How clotting is kept in check: natural anticoagulants and fibrinolysis

A cascade that amplifies itself needs brakes, or a small cut would clot the whole circulation. Antithrombin, a plasma protein, inactivates thrombin and factor Xa, along with IXa and XIa; heparin works by making antithrombin act far faster. Protein C, activated when thrombin binds thrombomodulin on healthy endothelium, works with its cofactor protein S to destroy the cofactors Va and VIIIa, shutting down the two big complexes. Tissue factor pathway inhibitor (TFPI) blocks tissue factor–VIIa once a little Xa has been made. Finally, once the vessel has healed, the clot is removed by fibrinolysis: tissue plasminogen activator (tPA) converts plasminogen into plasmin, and plasmin digests fibrin into fragments, among them D-dimer, the fragment measured when a clot is suspected. On a diagram, these are best drawn as red inhibition lines and a separate fibrinolysis branch — and only when the request asks for them.

Anticoagulant drug targets on a coagulation cascade diagram

Pharmacology courses use the cascade as a map of where drugs act, and each drug has one precise target. Warfarin blocks the recycling of vitamin K, so the liver makes less functional II, VII, IX, and X. Unfractionated heparin binds antithrombin and speeds its inhibition of thrombin and Xa; low-molecular-weight heparins such as enoxaparin act mainly on Xa, and fondaparinux on Xa only. The direct oral anticoagulants hit one enzyme each: rivaroxaban, apixaban, and edoxaban inhibit Xa, and dabigatran inhibits thrombin. Thrombolytics such as alteplase sit outside the cascade altogether: they are tPA, and they dissolve an existing clot by generating plasmin. A drug-target diagram draws each drug as a tag with an inhibition line ending on the right factor, which makes it obvious why, for example, warfarin raises the INR.

Bleeding disorders on the cascade

• Hemophilia A: deficiency of factor VIII, about 80 percent of hemophilia; prolonged aPTT, normal PT.
• Hemophilia B (Christmas disease): deficiency of factor IX; prolonged aPTT, normal PT.
• Hemophilia C: deficiency of factor XI; rare and usually milder.
• Factor XII deficiency: prolonged aPTT but no bleeding — evidence that contact activation is not how clotting starts in the body.
• Vitamin K deficiency or warfarin: low II, VII, IX, and X; PT/INR prolonged first because factor VII has the shortest half-life.
• Liver disease: most clotting factors are made in the liver, so several fall together.

How to draw a clotting cascade diagram by hand

If you need to sketch the cascade in an exam, draw a large Y. Put the extrinsic pathway on the upper right because it is short: write "tissue factor + VII". Put the intrinsic pathway on the upper left as a column: XII, XI, IX, and write VIII beside IX as its partner. Bring both arms down to a single box, X, at the fork, and write V beside it. Below that, write II → IIa (prothrombin to thrombin), then I → Ia (fibrinogen to fibrin), and finish with XIII cross-linking the fibrin. Add "Ca²⁺" next to the two complexes, and you have every factor in the classic picture in about a minute. If the question asks about tests, draw the aPTT bracket down the left arm and the common pathway, and the PT bracket down the right arm and the common pathway.

What to check before you use a coagulation cascade diagram

• Read every numeral: XI and IX, and Ia and IIa, are the pairs most often swapped.
• Look for a factor VI. There should never be one.
• Check the columns: XII, XI, IX, VIII intrinsic; tissue factor and VII extrinsic; X, V, II, I, XIII common.
• Check the meeting point: both pathways activate factor X in the classic diagram.
• Check the cofactors: VIIIa partners IXa and Va partners Xa; neither is drawn as an enzyme step.
• Check the ending: thrombin makes fibrin; XIIIa cross-links it.
• Check the arrows: every one points from trigger toward the clot, except feedback arrows, which should be dashed.